Arkolith/Insider Trading/BBI/Form 4

Sklawer Andrew D

COO and SecretaryBrickell Biotech, Inc. (BBI) · full profile →Form 4 · filed May 9, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 5, 2022Grant(A)450K—$0450K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000819050-22-000039) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML